Theraclion S.A.
ALTHE.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | €15,346 | €16,692 | €17,744 |
| - Cash | €1,555 | €4,171 | €3,898 | €7,815 |
| + Debt | €4,297 | €1,296 | €1,624 | €1,951 |
| Enterprise Value | – | €12,471 | €14,418 | €11,880 |
| Revenue | €834 | €388 | €442 | €841 |
| % Growth | 114.8% | -12.1% | -47.5% | – |
| Gross Profit | -€2,948 | -€4,036 | -€3,131 | -€415 |
| % Margin | -353.5% | -1,039.3% | -708.4% | -49.3% |
| EBITDA | -€2,764 | -€2,894 | -€2,774 | -€1,629 |
| % Margin | -331.4% | -745.3% | -627.5% | -193.6% |
| Net Income | -€2,538 | -€3,394 | -€2,363 | -€1,199 |
| % Margin | -304.3% | -873.9% | -534.6% | -142.5% |
| EPS Diluted | -0.055 | -0.073 | -0.052 | -0.026 |
| % Growth | 25.1% | -41.6% | -97.3% | – |
| Operating Cash Flow | -€3,563 | -€1,401 | -€1,510 | -€1,059 |
| Capital Expenditures | -€211 | -€57 | -€45 | €1,059 |
| Free Cash Flow | -€3,774 | -€1,458 | -€1,555 | €0 |